A detailed history of Susquehanna Fundamental Investments, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 64,059 shares of STAA stock, worth $1.71 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
64,059
Previous 71,339 10.2%
Holding current value
$1.71 Million
Previous $2.73 Billion 11.68%
% of portfolio
0.07%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$38.07 - $52.25 $277,149 - $380,380
-7,280 Reduced 10.2%
64,059 $3.05 Billion
Q1 2024

May 07, 2024

BUY
$27.67 - $39.61 $1.97 Million - $2.83 Million
71,339 New
71,339 $2.73 Billion
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $515 - $838
-11 Reduced 0.08%
13,781 $668,000
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $680,454 - $1.08 Million
9,645 Added 232.58%
13,792 $973,000
Q1 2022

May 16, 2022

BUY
$57.98 - $93.5 $240,443 - $387,744
4,147 New
4,147 $331,000
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $461,224 - $669,619
-5,240 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$122.75 - $162.68 $736,500 - $976,080
-6,000 Reduced 53.38%
5,240 $673,000
Q2 2021

Aug 11, 2021

SELL
$105.76 - $154.96 $3.18 Million - $4.66 Million
-30,100 Reduced 72.81%
11,240 $1.71 Million
Q1 2021

May 17, 2021

BUY
$78.5 - $126.48 $34,540 - $55,651
440 Added 1.08%
41,340 $4.36 Million
Q4 2020

Feb 16, 2021

SELL
$55.93 - $82.78 $201,348 - $298,008
-3,600 Reduced 8.09%
40,900 $3.24 Million
Q3 2020

Nov 16, 2020

BUY
$45.65 - $61.81 $493,020 - $667,548
10,800 Added 32.05%
44,500 $2.52 Million
Q2 2020

Aug 14, 2020

BUY
$29.15 - $61.54 $982,355 - $2.07 Million
33,700 New
33,700 $2.07 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.